Health
LAKEPORT, Calif. – The Sutter Lakeside Hospital Volunteer Auxiliary is proud to announce the delivery of new “mommy rockers” and family daybeds, which arrived at the Family Birthing Center at Sutter Lakeside Hospital this summer.
“We wanted to make our Family Birth Center patients and their families as comfortable as possible during this very special time in their lives,” Auxiliary President Joan Taylor said.
The new daybeds provided by the auxiliary are couches during daylight hours and convert to beds for members of the patient’s support team at night.
Jackie Rad, R.N.C., clinical coordinator of the Family Birthing Center added, “We’d like to express our deep gratitude to the auxiliary for this donation. Our patients and their families love the new rockers and the daybeds. And our staff really appreciates the convenience of furniture that serves two purposes. The auxiliary’s generosity and commitment to Sutter Lakeside Hospital makes our birthing suites even more patient-centered and family-friendly.”
This $16,000 furniture donation to the Family Birth Center is the latest example of the auxiliary’s investment in Sutter Lakeside Hospital’s success.
In 2010, they donated $10,000 to the Stroke Telemedicine Program, and in 2011 the Auxiliary gave $20,000 to the campaign to build an Outdoor Mobility Park on campus.
Each year, they provide graduating Lake County high school seniors with $5,000 in scholarships.
“We are extremely proud of our ability to promote the comfort and care of our patients, and we particularly enjoy helping our students further their education in the medical field,” said Taylor.
The Sutter Lakeside Hospital Volunteer Auxiliary is currently accepting new volunteer applications. Interested parties can pick up an application in the auxiliary’s gift shop, located in the main lobby of the hospital between 8 a.m. and 4 p.m. Monday through Friday and from 9 a.m. to 3 p.m. on Saturday.
Proceeds from the gift shop enable the auxiliary to continue investing in the hospital and in the health care of the Lake County community.
If you have questions about volunteering, please contact Joan Taylor at 707-349-2342 or send an email to
- Details
- Written by: Editor
A research report published in the September 2012 issue of the Journal of Leukocyte Biology offers a possible explanation of why some cancer vaccines are not as effective as hoped, while at the same time identifies a new therapeutic strategy for treating autoimmune problems.
In the report, scientists suggest that cancer, even in the very early stages, produces a negative immune response from dendritic cells, which prevent lymphocytes from working against the disease.
Although problematic for cancer treatment, these flawed dendritic cells could be valuable therapeutic tools for preventing the immune system from attacking what it should not, as is the case with autoimmune disorders and organ transplants.
“Immunotherapy of cancer has been an elusive research target that, though promising, never seems to ‘get there,’” said José Alexandre M. Barbuto, Ph.D., from the Laboratory of Tumor Immunology, Department of Immunology, Institute of Biomedical Sciences at the University of São Paulo, in São Paulo, Brazil.
“This study helps us to better understand the mechanisms by which tumors avoid immune recognition and rejection and may, therefore, teach us how to actually engage effectively the immune system in the fight against tumors, thus achieving much better clinical responses and, consequently, quality of life, in our therapeutic approaches,” Barbuto said.
To make this discovery, researchers obtained a small sample of blood from breast cancer patients, and from healthy volunteers. The blood cells were then separated and induced to become dendritic cells.
Researchers then used these laboratory-generated dendritic cells to induce responses from other immune system cells, namely lymphocytes.
While dendritic cells from the healthy donors induced vigorous lymphocytic responses, dendritic cells from cancer patients induced mainly the activation of a specific type of lymphocyte, a regulatory lymphocyte that works as a “brake” for other types of lymphocytes.
“Understanding why the immune system does not recognize and eliminate cancer is critical to developing effective immunotherapies to fight the disease,” said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology. “Immunologists have been trying to unravel the answer to this question for decades and have realized that the problem is both on the immune system side, and because cancer cells appear to actively ‘fly under the radar’ avoiding immune system detection. This article offers insights into the underlying mechanisms regulating a key immune cell type, the dendritic cell, involved in initiating anti-tumor responses.”
- Details
- Written by: Editor
How to resolve AdBlock issue?